A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain

PHASE2TerminatedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

September 13, 2023

Primary Completion Date

August 12, 2024

Study Completion Date

December 3, 2024

Conditions
PainOsteoarthritis, Knee
Interventions
DRUG

GSK3858279

GSK3858279 will be administered.

DRUG

Placebo

Placebo will be administered.

Trial Locations (93)

1118

GSK Investigational Site, Ciudad AutOnoma de Buenos Aire

1619

GSK Investigational Site, Gauteng

1643

GSK Investigational Site, Buenos Aires-San Isidro

2010

GSK Investigational Site, Sydney

2019

GSK Investigational Site, Botany

2113

GSK Investigational Site, Johannesburg

2289

GSK Investigational Site, Kotara

3124

GSK Investigational Site, Camberwell

7130

GSK Investigational Site, Cape Town

7405

GSK Investigational Site, Cape Town

7600

GSK Investigational Site, Stellenbosch

10117

GSK Investigational Site, Berlin

14221

GSK Investigational Site, Williamsville

15006

GSK Investigational Site, A Coruña

15702

GSK Investigational Site, Santiago de Compostela

16635

GSK Investigational Site, Duncansville

17019

GSK Investigational Site, La Rochelle

20095

GSK Investigational Site, Hamburg

21200

GSK Investigational Site, Mexicali

22415

GSK Investigational Site, Hamburg

22911

GSK Investigational Site, Charlottesville

27000

GSK Investigational Site, Torreón

27410

GSK Investigational Site, Greensboro

28046

GSK Investigational Site, Madrid

31000

GSK Investigational Site, Chihuahua City

33024

GSK Investigational Site, Cooper City

33173

GSK Investigational Site, Miami

33185

GSK Investigational Site, Miami

33189

GSK Investigational Site, Cutler Bay

34000

GSK Investigational Site, Montpellier

39008

GSK Investigational Site, Santander

39120

GSK Investigational Site, Magdeburg

40107

GSK Investigational Site, Dax

40213

GSK Investigational Site, Louisville

41014

GSK Investigational Site, Seville

44650

GSK Investigational Site, Guadalajara

67207

GSK Investigational Site, Wichita

70115

GSK Investigational Site, New Orleans

75012

GSK Investigational Site, Paris

85925

GSK Investigational Site, La Roche-sur-Yon

89052

GSK Investigational Site, Henderson

90703

GSK Investigational Site, Cerritos

92647

GSK Investigational Site, Huntington Beach

95054

GSK Investigational Site, Santa Clara

100083

GSK Investigational Site, Beijing

100730

GSK Investigational Site, Beijing

110022

GSK Investigational Site, Shenyang

130021

GSK Investigational Site, Changchun

200011

GSK Investigational Site, Shanghai

200040

GSK Investigational Site, Shanghai

200065

GSK Investigational Site, Shanghai

210009

GSK Investigational Site, Nanjing

300192

GSK Investigational Site, Tianjin

412007

GSK Investigational Site, Zhuzhou

510000

GSK Investigational Site, Guangzhou

610041

GSK Investigational Site, Chengdu

C1128AAF

GSK Investigational Site, Buenos Aires

C1417

GSK Investigational Site, Ciudad Autonoma Buenos Aires

C1046AAQ

GSK Investigational Site, Ciudad Autonoma de Buenos Aire

B7600FYK

GSK Investigational Site, Mar del Plata

V8V 4A1

GSK Investigational Site, Victoria

L6T 0G1

GSK Investigational Site, Brampton

N1H 1B1

GSK Investigational Site, Guelph

N7T 4X3

GSK Investigational Site, Sarnia

M5T 2S8

GSK Investigational Site, Toronto

M9V 4B4

GSK Investigational Site, Toronto

K0C 2K0

GSK Investigational Site, Winchester

J6E 6A9

GSK Investigational Site, Joliette

J1L 0H8

GSK Investigational Site, Sherbrooke

G9A 3X2

GSK Investigational Site, Trois-Rivières

010017

GSK Investigational Site, Hohhot

050051

GSK Investigational Site, Shijiazhuang

834-0115

GSK Investigational Site, Fukuoka

300-1234

GSK Investigational Site, Ibaraki

300-1253

GSK Investigational Site, Ibaraki

390-8601

GSK Investigational Site, Nagano

395-8505

GSK Investigational Site, Nagano

543-0027

GSK Investigational Site, Osaka

330-0074

GSK Investigational Site, Saitama

693-8501

GSK Investigational Site, Shimane

103-0027

GSK Investigational Site, Tokyo

104-0031

GSK Investigational Site, Tokyo

113-8431

GSK Investigational Site, Tokyo

CP 97070

GSK Investigational Site, Mérida

03080

GSK Investigational Site, Seoul

06973

GSK Investigational Site, Seoul

07441

GSK Investigational Site, Seoul

08430

GSK Investigational Site, Barcelona

08540

GSK Investigational Site, Barcelona

FY2 0JH

GSK Investigational Site, Blackpool

WS11 0BN

GSK Investigational Site, Cannock

EN5 3DJ

GSK Investigational Site, London

M13 9NQ

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY